{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:20:25Z","timestamp":1707524425412},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,16]]},"DOI":"10.7759\/cureus.18830","type":"journal-article","created":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T09:46:39Z","timestamp":1634463999000},"source":"Crossref","is-referenced-by-count":1,"title":["An Unusual Presentation of Community-Acquired Methicillin-Resistant Staphylococcus aureus Infection in a Child Treated With Linezolid"],"prefix":"10.7759","author":[{"given":"Amer","family":"Alshengeti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafid","family":"Alamri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reem","family":"Tharwat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatem","family":"Alahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulsalam","family":"Alawfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maher","family":"Arkoubi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousef","family":"Alrashidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.122108599","article-title":"The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)","volume":"99","author":"Enright MC","year":"2002","unstructured":"Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A. 2002, 99:7687-92. 10.1073\/pnas.122108599","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1086\/499815","article-title":"Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections","volume":"42","author":"Seybold U","year":"2006","unstructured":"Seybold U, Kourbatova EV, Johnson JG, et al.. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis. 2006, 42:647-56. 10.1086\/499815","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/1319-1683.74320","article-title":"A review of community-acquired methicillin-resistant Staphylococcus aureus for primary care physicians","volume":"17","author":"Bukharie HA","year":"2010","unstructured":"Bukharie HA. A review of community-acquired methicillin-resistant Staphylococcus aureus for primary care physicians. J Family Community Med. 2010, 17:117-20. 10.4103\/1319-1683.74320","journal-title":"J Family Community Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1086\/507637","article-title":"Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection","volume":"43","author":"Pannaraj PS","year":"2006","unstructured":"Pannaraj PS, Hulten KG, Gonzalez BE, Mason EO Jr, Kaplan SL. Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2006, 43:953-60. 10.1086\/507637","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/adc.87.4.312","article-title":"Clinical and radiographic spectrum of septic pulmonary embolism","volume":"87","author":"Wong KS","year":"2002","unstructured":"Wong KS, Lin TY, Huang YC, Hsia SH, Yang PH, Chu SM. Clinical and radiographic spectrum of septic pulmonary embolism. Arch Dis Child. 2002, 87:312-5. 10.1136\/adc.87.4.312","journal-title":"Arch Dis Child"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu C","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, et al.. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011, 52:e18-55. 10.1093\/cid\/ciq146","journal-title":"Clin Infect Dis"},{"key":"ref7","article-title":"Septic pulmonary embolism secondary to Staphylococcus aureus septic thrombophlebitis in a pediatric patient","volume":"34","author":"Thabet FC","year":"2013","unstructured":"Thabet FC, Alhejaili AS, Alodayani AN, Chehab MS. Septic pulmonary embolism secondary to Staphylococcus aureus septic thrombophlebitis in a pediatric patient. Saudi Med J. 2013, 34:1080-2.","journal-title":"Saudi Med J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903512057","article-title":"The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid","volume":"26","author":"Stein GE","year":"2010","unstructured":"Stein GE, Wells EM. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid. Curr Med Res Opin. 2010, 26:571-88. 10.1185\/03007990903512057","journal-title":"Curr Med Res Opin"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182a26774","article-title":"A randomized controlled trial of a vancomycin loading dose in children","volume":"32","author":"Demirjian A","year":"2013","unstructured":"Demirjian A, Finkelstein Y, Nava-Ocampo A, et al.. A randomized controlled trial of a vancomycin loading dose in children. Pediatr Infect Dis J. 2013, 32:1217-23. 10.1097\/INF.0b013e3182a26774","journal-title":"Pediatr Infect Dis J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa303","article-title":"Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists","volume":"71","author":"Rybak MJ","year":"2020","unstructured":"Rybak MJ, Le J, Lodise TP, et al.. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis. 2020, 71:1361-4. 10.1093\/cid\/ciaa303","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181906e40","article-title":"Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate","volume":"28","author":"Frymoyer A","year":"2009","unstructured":"Frymoyer A, Hersh AL, Benet LZ, Guglielmo BJ. Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate. Pediatr Infect Dis J. 2009, 28:398-402. 10.1097\/INF.0b013e3181906e40","journal-title":"Pediatr Infect Dis J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy495","article-title":"Vancomycin monotherapy may be insufficient to treat methicillin-resistant Staphylococcus aureus coinfection in children with influenza-related critical illness","volume":"68","author":"Randolph AG","year":"2019","unstructured":"Randolph AG, Xu R, Novak T, et al.. Vancomycin monotherapy may be insufficient to treat methicillin-resistant Staphylococcus aureus coinfection in children with influenza-related critical illness. Clin Infect Dis. 2019, 68:365-72. 10.1093\/cid\/ciy495","journal-title":"Clin Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-138-2-200301210-00015","article-title":"Linezolid: the first oxazolidinone antimicrobial","volume":"138","author":"Moellering RC","year":"2003","unstructured":"Moellering RC. Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med. 2003, 138:135-42. 10.7326\/0003-4819-138-2-200301210-00015","journal-title":"Ann Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000078160.29072.42","article-title":"Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children","volume":"22","author":"Kaplan SL","year":"2003","unstructured":"Kaplan SL, Deville JG, Yogev R, et al.. Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children. Pediatr Infect Dis J. 2003, 22:677-86. 10.1097\/01.inf.0000078160.29072.42","journal-title":"Pediatr Infect Dis J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000087022.58089.d8","article-title":"Safety and tolerability of linezolid in children","volume":"22","author":"Saiman L","year":"2003","unstructured":"Saiman L, Goldfarb J, Kaplan SA, Wible K, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB. Safety and tolerability of linezolid in children. Pediatr Infect Dis J. 2003, 22:S193-200. 10.1097\/01.inf.0000087022.58089.d8","journal-title":"Pediatr Infect Dis J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.08.001","article-title":"Effectiveness and tolerability of prolonged linezolid treatment for chronic osteomyelitis: a retrospective study","volume":"28","author":"Senneville E","year":"2006","unstructured":"Senneville E, Legout L, Valette M, et al.. Effectiveness and tolerability of prolonged linezolid treatment for chronic osteomyelitis: a retrospective study. Clin Ther. 2006, 28:1155-63. 10.1016\/j.clinthera.2006.08.001","journal-title":"Clin Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31812e62dc","article-title":"Experience with linezolid therapy in children with osteoarticular infections","volume":"26","author":"Chen CJ","year":"2007","unstructured":"Chen CJ, Chiu CH, Lin TY, Lee ZL, Yang WE, Huang YC. Experience with linezolid therapy in children with osteoarticular infections. Pediatr Infect Dis J. 2007, 26:985-8. 10.1097\/INF.0b013e31812e62dc","journal-title":"Pediatr Infect Dis J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/72409-an-unusual-presentation-of-community-acquired-methicillin-resistant-staphylococcus-aureus-infection-in-a-child-treated-with-linezolid","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:05Z","timestamp":1707507305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/72409-an-unusual-presentation-of-community-acquired-methicillin-resistant-staphylococcus-aureus-infection-in-a-child-treated-with-linezolid"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,16]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.18830","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,16]]}}}